Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AI Revolution in Finance: NYC FinTech Forum Highlights Industry's Tech-Driven Future
-
Scientology Network Takes Viewers Inside Bridge Publications, the Ultimate 21st-Century Publishing Facility
-
Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
-
Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024
-
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
-
SVTA Announces New Board Officers
-
Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience
-
Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESM
-
Successful "DeSci Seoul 2024 Conference" Hosted by Hippocrat and ResearchHub Paves the Way for the Future of Decentralized Science
-
Introducing Printblur's 2024 Halloween-Inspired Product Lineup: Personalization, Diversity, and Global Presence
-
KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Overall Survival (OS) Versus Trastuzumab and Chemotherapy Alone in First-Line Treatment of Patients With HER2-Positi
-
RYBREVANT® (amivantamab-vmjw) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer
-
Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on
-
Absolute Janitorial Services Earns Prestigious Women-Owned Business Certification from WBENC
-
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug
-
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
-
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
-
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
-
Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
-
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
-
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
-
Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer
-
"Ashes of the Kingdom" Breaks Barriers to Captivate the World: Chinese Female-Oriented Games Showcase Global Impact
-
IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer
-
iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non
-
The Second Overseas Production Model of NETA, the NETA X, Rolls Off the Production Line at the Indonesia Smart Factory
-
TIME, Statista Name Three SM companies Among World's Best Companies
-
Unveil Delightful Wine and Champagne Gifts To Share This Thanksgiving
-
The HOTH Celebrates Over a Decade of SEO Excellence with Client Success Stories
-
Be One Family Office and COPX.AI Forge Strategic Partnership to Redefine Family Wealth Management
-
LCI (LOVECHAIN) Is Now Available for Trading on LBank Exchange
-
MSquare Technology Showcases Leadership in IP and Chiplet Innovation at the AI Hardware & Edge AI Summit
-
Xinhua Silk Road: China's services trade fair promotes shared prosperity among global businesses
-
NiceTop™️ Unveils New Hair Growth Supplement Amid Product Line Expansion
-
Guide On Running Social Media Contests & Giveaways Released By ScottHall.com
-
New York Business Growth Consultancy: Mentorship & Talent Retention Guide Launch
-
Sinopec Wins Best Environmental Protection Case at the First Sino-European Corporate ESG Best Practice Conference in Frankfurt
-
XCMG Unveils Major Lineup for MinExpo 2024, Showcasing Advanced Mining Solutions
-
WNP: Redefining Skincare with Innovation
-
Tumwater Professional Content Marketing Campaigns Launched By Search Shark Media
-
Eco Oro Announces Change in Management Team and Board
-
Masimo Partners with Google to Develop a Reference Platform That Helps Device Manufacturers Bring High-performing Wear OS Smartwatches to Market
-
VIZSLA SILVER UPDATES AT-THE-MARKET EQUITY PROGRAM
-
SCF Acquires Newpark Fluids Systems
-
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Gran Tierra Energy Inc. Announces Pricing of an Additional $150 Million Aggregate Principal Amount of its 9.500% Senior Secured Amortizing Notes due 2029
-
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
If you purchased Breyers® Natural Vanilla ice cream as a consumer in the United States from April 21, 2016 through August 14, 2024, you may be eligible for a cash payment from a class action Settleme
-
KBW Announces Index Rebalancing for Third-Quarter 2024
